The struggling biotech firm, NovaGen Therapeutics, faced severe financial difficulties stemming from disappointing clinical trials and growing debt. Their internal management lacked the expertise to address https://haseebdafs567246.blognody.com/50213899/biotech-cfo-services-a-case-study-in-financial-restructuring